Effectiveness of a bioactive food compound in anthropometric measures of individuals with HIV/AIDS: A nonrandomized trial.
Rosângela Dos Santos FerreiraRita de Cássia Avellaneda GuimarãesElenir Rose Jardim Cury PontesLígia Aurélio Bezerra Maranhão MendonçaKarine de Cássia FreitasPriscila Aiko HianePublished in: PloS one (2018)
The BFC consumed by HIV patients undergoing HAART allowed the maintenance of anthropometric measures without increasing the mean values of conicity index, suggesting that the consumption of this bioactive compound protects the individual against the development of metabolic syndrome (MeS) in patients infected with HIV undergoing antiretroviral therapy.
Keyphrases
- antiretroviral therapy
- hiv aids
- hiv infected
- hiv infected patients
- hiv positive
- human immunodeficiency virus
- metabolic syndrome
- patients undergoing
- end stage renal disease
- body composition
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- newly diagnosed
- clinical trial
- prognostic factors
- study protocol
- hepatitis c virus
- insulin resistance
- systematic review
- patient reported outcomes
- skeletal muscle
- risk assessment
- cardiovascular disease
- phase ii